Alnylam Pharmaceuticals, Inc. : Alnylam to Webcast Presentation at Upcoming Investor Conferences (4-Traders) Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2013 at 11:10 a.m. ET at the Grand Hyatt in New York City. In addition, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) management will present a company overview at the Stifel 2013 Healthcare Conference on Thursday, September 12, 2013 at 10:55 a.m. ET at the Four Seasons Hotel in Boston.
Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling (Insider Monkey) If you're a Synta Pharmaceuticals Corp. (NASDAQ:SNTA) investor, this data will make you want to rethink your position. Just sayin'. If you were to ask many of your peers, hedge funds are assumed to be overrated, outdated financial vehicles of a forgotten age. Although there are over 8,000 hedge funds trading today, this site focuses on the crème de la crème of this club, close to 525 funds. Analysts calculate that this group has its hands on the lion's share of all hedge funds' total capital, and by watching their highest performing equity investments, we've brought to light a number of investment strategies that have historically outperformed the broader indices.
Shares in Inovio Pharmaceuticals Inc. Finished Flat on Wednesday (INO) (SBWire) Inovio Pharmaceuticals Inc (NYSEMKT:INO) is changing the landscape of vaccinations to prevent and cure modern malignancies and complicated contagious illnesses. Its SynCon vaccinations, along with its exclusive electroporation distribution, are producing best-in-class defense reactions, with healing T-cell reactions going above other technology in terms of scale, depth, and reaction rate. Human data to date have shown a positive safety information. Inovio Pharmaceuticals Inc (NYSEMKT:INO)'s lead vaccine, a healing against HPV-caused pre-cancers and malignancies, is in stage II.
Synta Pharmaceuticals Corp. : Synta to Present at the Stifel 2013 Healthcare Conference (4-traders) Synta Pharmaceuticals Corp. (NASDAQ:SNTA) announced today that the Company will present at the Stifel 2013 Healthcare Conference on Wednesday, September 11, at 3:15 p.m. (EDT) in Boston. Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures.
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences (The Wall St Journal) Inovio Pharmaceuticals Inc (NYSEMKT:INO), announced today that Dr. J. Joseph Kim, President and CEO, will be presenting a corporate overview of the company at the Rodman & Renshaw Global Investment Conference and the Stifel Nicolaus Weisel Healthcare Conference.